Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Felker, GM; Butler, J; Ibrahim, NE; Piña, IL; Maisel, A; Bapat, D; Camacho, A; Ward, JH; Williamson, KM; Solomon, SD; Januzzi, JL; PROVE-HF Investigators,

Published Date

  • July 13, 2021

Published In

Volume / Issue

  • 144 / 2

Start / End Page

  • 180 - 182

PubMed ID

  • 34251893

Pubmed Central ID

  • PMC8270225

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.121.054034

Language

  • eng

Conference Location

  • United States